South San Francisco, CA-based Oxigene (NASDAQ: OXGN), a developer of cancer treatments, named Matthew Loar as its new chief financial officer. Loar was previously CFO of KineMed, a privately held biotech in Emeryville, CA.
Alex Lash is Xconomy's National Biotech Editor. He is based in San Francisco. Follow @alexlash